Aaron Nagiel

Aaron Nagiel

Auto-generated profile, based on publicly available information

Aaron Nagiel

Vision Center - Ophthalmology, Department of Surgery, Children's Hospital Los Angeles, Los Angeles, CA, USA; Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
SSSteven Schwartz
Steven Schwartz
GTGavin Tan
Gavin Tan
HHHamid Hosseini
Hamid Hosseini
ANAaron Nagiel
Aaron Nagiel
Advanced macular degeneration is an important cause of vision loss in the United States with over 2 million people affected by the disease. Despite substantial progress in the development of new therapies for wet AMD, the severe visual impairment associated with geographic atrophy in dry AMD or Stargardt disease remains untreatable. Recently, two phase I/II studies involving 18 patients with these diseases have demonstrated that it is possible to safely implant human embryonic stem cell–derived RPE (hESC-RPE) in an attempt to rescue photoreceptors and visual function. The anatomical and functional results are encouraging, with more than half of treated patients experiencing sustained improvements in visual acuity and demonstrating evidence of possible cellular engraftment. However, any conclusions remain tempered by the relatively short follow-up time, lack of a formal control group, poor initial visual acuity, and small number of patients. Aside from an instance of postoperative infectious endophthalmitis, no adverse events related to the cell therapy, such as hyperproliferation, tumorigenicity, or rejection-related inflammation were noted in this initial cohort of 18 patients. These first-in-human safety studies have opened the door to future studies enrolling patients with less advanced disease, treating other diseases that result in RPE loss, employing shorter immunosuppressive regimens, and using alternative strategies for RPE transplantation such as sheets of cells with or without scaffolding to mimic Bruch's membrane. The ultimate goal of these initial safety studies is to promote continued translation of complex biological therapies into meaningful treatment strategies that may address unmet medical needs.

1 April 2016 in Retina
Verified
Journal Article
Closed access
ANAaron Nagiel
Aaron Nagiel
RLRobert A. Lalane
Robert A. Lalane
SSSriniVas R. Sadda
SriniVas R. Sadda
SSSteven D. Schwartz
Steven D. Schwartz
To review the basic principles of ultra-widefield fundus imaging and discuss its clinical utility for a variety of retinal and choroidal disorders. A systematic review of the PubMed database was performed using the search terms Optos, optomap, panoramic, ultra-widefield, wide-angle, and ellipsoid mirror. This yielded 158 publications of which 128 were selected based on content and relevance. A total of 128 articles pertaining to ultra-widefield imaging were cited in this review. Optos ultra-widefield imaging has become an essential tool for the identification of peripheral retinal and vascular pathology. The high resolution and multimodal capabilities of this device are also providing new insights into a variety of disorders, even those that primarily involve the posterior pole. Although the presence of artifact and the need for clinical validation are significant hurdles to more widespread use, ultra-widefield is evolving to become the standard-of-care imaging modality for many diseases and is finding new clinical and research applications such as for screening and telemedicine.

25 May 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
NKNathaniel Kastan
Nathaniel Kastan
KGKsenia Gnedeva
Ksenia Gnedeva
TATheresa Alisch
Theresa Alisch
APAleksandra A. Petelski
Aleksandra A. Petelski
DHDavid J. Huggins
David J. Huggins
AHA. J. Hudspeth
A. J. Hudspeth
Hippo signaling is an evolutionarily conserved pathway that restricts growth and regeneration predominantly by suppressing the activity of the transcriptional coactivator Yap. Using a high-throughput phenotypic screen, we identified a potent and non-toxic activator of Yap. In vitro kinase assays show that the compound acts as an ATP-competitive inhibitor of Lats kinases—the core enzymes in Hippo signaling. The substance prevents Yap phosphorylation and induces proliferation of supporting cells in the murine inner ear, murine cardiomyocytes, and human Müller glia in retinal organoids. RNA sequencing indicates that the inhibitor reversibly activates the expression of transcriptional Yap targets: upon withdrawal, a subset of supporting-cell progeny exits the cell cycle and upregulates genes characteristic of sensory hair cells. Our results suggest that the pharmacological inhibition of Lats kinases may promote initial stages of the proliferative regeneration of hair cells, a process thought to be permanently suppressed in the adult mammalian inner ear.

20 August 2008 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
ANAaron Nagiel
Aaron Nagiel
DADaniel Andor-Ardó
Daniel Andor-Ardó
AHA. J. Hudspeth
A. J. Hudspeth
The proper wiring of the vertebrate brain represents an extraordinary developmental challenge, requiring billions of neurons to select their appropriate synaptic targets. In view of this complexity, simple vertebrate systems provide necessary models for understanding how synaptic specificity arises. The posterior lateral-line organ of larval zebrafish consists of polarized hair cells organized in discrete clusters known as neuromasts. Here we show that each afferent neuron of the posterior lateral line establishes specific contacts with hair cells of the same hair-bundle polarity. We quantify this specificity by modeling the neuron as a biased selector of hair-cell polarity and find evidence for bias from as early as 2.5 d after fertilization. More than half of the neurons form contacts on multiple neuromasts, but the innervated organs are spatially consecutive and the polarity preference is consistent. Using a novel reagent for correlative electron microscopy, HRP-mCherry, we show that these contacts are indeed afferent synapses bearing vesicle-loaded synaptic ribbons. Moreover, afferent neurons reassume their biased innervation pattern after hair-cell ablation and regeneration. By documenting specificity in the pattern of neuronal connectivity during development and in the context of organ regeneration, these results establish the posterior lateral-line organ as a vertebrate system for thein vivostudy of synaptic target selection.

8 April 2021 in Ophthalmology Retina
Verified
Journal Article
Closed access
WGWilliam S. Gange
William S. Gange
RSRobert A. Sisk
Robert A. Sisk
CBCagri G. Besirli
Cagri G. Besirli
TLThomas C. Lee
Thomas C. Lee
MHMargaret Havunjian
Margaret Havunjian
ANAaron Nagiel
Aaron Nagiel

1 April 2015 in Retina
Verified
Journal Article
Closed access
ANAaron Nagiel
Aaron Nagiel
DSDavid Sarraf
David Sarraf
SSSrinivas R. Sadda
Srinivas R. Sadda
RSRichard F. Spaide
Richard F. Spaide
JJJesse J. Jung
Jesse J. Jung
KFK. Bailey Freund
K. Bailey Freund
To demonstrate the evolution and treatment response of Type 3 neovascularization using spectral domain optical coherence tomography. We retrospectively analyzed 40 eyes treated with intravitreal anti-vascular endothelial growth factor therapy for Type 3 neovascularization over a variable follow-up period. In 17 eyes, spectral domain optical coherence tomography captured the development of Type 3 neovascularization from punctate hyperreflective foci that preceded any outer retinal defect. The more mature Type 3 lesions were associated with outer retinal disruption and adjacent cystoid macular edema. In addition, 37 of 40 Type 3 lesions (93%) were associated with an underlying pigment epithelial detachment, of which 26 (70%) were drusenoid, 6 (16%) serous, and 5 (14%) mixed. Type 3 vessels appeared to leak fluid into the pigment epithelial detachment cavity, creating serous pigment epithelial detachments as large as 925 μm in maximal height. Treatment with anti-vascular endothelial growth factor agents led to prompt involution of the lesion and resorption of the intraretinal and subretinal pigment epithelium fluid after one or two injections (median = 1). In some eyes with age-related macular degeneration, the earliest sign of Type 3 neovascularization is punctate hyperreflective foci above the external limiting membrane. The mature Type 3 lesions and associated serous pigment epithelial detachments are highly responsive to anti-vascular endothelial growth factor therapy.